Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TYROBP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | AIM1L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | RNASE13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CHST7 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | RASEF | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | GAPDHS | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | PRR15 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | KLF5 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
mRNA | NEK10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | STX6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |